Finance

Beta
Lists
6534:TPE
CH Biotech R&D Co Ltd
NT$89,10
+0,45%
(+0,40) 1D
9 Jun., 13:30:32 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6534...
Open
NT$88,70
High
NT$90,10
Low
NT$88,70
Mkt. cap
9,16 mjd
Avg. vol.
163,90 k
Volume
68,64 k
Dividend
5,39%
Quarterly dividend
NT$1,20
Ex-dividend date
21 Aug. 2025
P/E ratio
18,75
52-wk high
NT$123,50
52-wk low
NT$75,90
EPS
NT$4,75
No. of employees
22
Open
NT$88,70
High
NT$90,10
Low
NT$88,70
Mkt. cap
9,16 mjd
Avg. vol.
163,90 k
Volume
68,64 k
Dividend
5,39%
Quarterly dividend
NT$1,20
Ex-dividend date
21 Aug. 2025
P/E ratio
18,75
52-wk high
NT$123,50
52-wk low
NT$75,90
EPS
NT$4,75
No. of employees
22
News stories
From sources across the web
About CH Biotech R&D Co Ltd
CEO-
Employees22
Founded2013
Headquarters-
Sector-
Websitechbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
420,48 m
216,68 m
328,38 m
869,50 m
Cost of goods sold
71,75 m
44,23 m
63,38 m
120,11 m
Cost of revenue
71,75 m
44,23 m
63,38 m
120,11 m
Research and development expenses
90,77 m
121,72 m
98,86 m
99,04 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107,70 m
99,03 m
124,14 m
132,18 m
Operating expense
208,89 m
221,16 m
223,35 m
231,23 m
Total operating expenses
280,64 m
265,39 m
286,73 m
351,33 m
Operating income
139,83 m
-48,71 m
41,65 m
518,17 m
Other non operating income
1,26 m
1,70 m
1,73 m
1,08 m
EBT including unusual items
32,51 m
-21,67 m
59,12 m
532,25 m
EBT excluding unusual items
32,51 m
-21,19 m
59,24 m
532,25 m
Income tax expense
-5,16 m
-4,69 m
15,34 m
105,55 m
Effective tax rate
-15,88%
21,64%
25,94%
19,83%
Other operating expenses
-
-
-
-
Net income
37,74 m
-16,94 m
43,80 m
426,70 m
Net profit margin
8,97%
-7,82%
13,34%
49,07%
Earnings per share
-
-
-
-
Interest and investment income
2,74 m
3,86 m
2,72 m
2,58 m
Interest expense
-4,60 m
-4,90 m
-3,58 m
-3,28 m
Net interest expenses
-1,86 m
-1,04 m
-853,00 k
-703,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
185,67 m
-2,48 m
88,81 m
566,17 m
Gain or loss from assets sale
-
478,00 k
122,00 k
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer